Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Melanie Cassella

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Annals of the New York Academy of Sciences|January 25, 2003
Lymphatic vessel activation in cancerMelanie Cassella, Mihaela Skobe
Cancer Research|March 3, 2006
Inhibition of VEGFR-3 activation with the antagonistic antibody more potently suppresses lymph node and distant metastases than inactivation of VEGFR-2Nicole Roberts, Bryan Kloos, Melanie Cassella, et al.
The Journal of Experimental Medicine|July 24, 2013
Tumor cell entry into the lymph node is controlled by CCL1 chemokine expressed by lymph node lymphatic sinusesSuvendu Das, Eliana Sarrou, Simona Podgrabinska, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Annals of the New York Academy of Sciences|January 25, 2003
Lymphatic vessel activation in cancerMelanie Cassella, Mihaela Skobe
Cancer Research|March 3, 2006
Inhibition of VEGFR-3 activation with the antagonistic antibody more potently suppresses lymph node and distant metastases than inactivation of VEGFR-2Nicole Roberts, Bryan Kloos, Melanie Cassella, et al.
The Journal of Experimental Medicine|July 24, 2013
Tumor cell entry into the lymph node is controlled by CCL1 chemokine expressed by lymph node lymphatic sinusesSuvendu Das, Eliana Sarrou, Simona Podgrabinska, et al.
Pageof 1